- Home
- BBDO vs NTRA Comparison
BBDO vs NTRA Comparison
Compare BBDO & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBDO
- NTRA
- Stock Information
- Founded
- BBDO 1943
- NTRA 2003
- Country
- BBDO Brazil
- NTRA United States
- Employees
- BBDO N/A
- NTRA N/A
- Industry
- BBDO Major Banks
- NTRA Medical Specialities
- Sector
- BBDO Finance
- NTRA Health Care
- Exchange
- BBDO Nasdaq
- NTRA Nasdaq
- Market Cap
- BBDO 28.5B
- NTRA 24.9B
- IPO Year
- BBDO N/A
- NTRA 2015
- Fundamental
- Price
- BBDO $2.78
- NTRA $172.22
- Analyst Decision
- BBDO Strong Buy
- NTRA Strong Buy
- Analyst Count
- BBDO 4
- NTRA 17
- Target Price
- BBDO $2.55
- NTRA $192.41
- AVG Volume (30 Days)
- BBDO 27.1K
- NTRA 1.1M
- Earning Date
- BBDO 10-29-2025
- NTRA 11-11-2025
- Dividend Yield
- BBDO 4.33%
- NTRA N/A
- EPS Growth
- BBDO 58.81
- NTRA N/A
- EPS
- BBDO 0.36
- NTRA N/A
- Revenue
- BBDO $16,114,445,927.00
- NTRA $1,964,250,000.00
- Revenue This Year
- BBDO $76.13
- NTRA $24.28
- Revenue Next Year
- BBDO $7.53
- NTRA $15.22
- P/E Ratio
- BBDO $8.28
- NTRA N/A
- Revenue Growth
- BBDO 27.09
- NTRA 44.38
- 52 Week Low
- BBDO $1.71
- NTRA $117.27
- 52 Week High
- BBDO $3.00
- NTRA $183.00
- Technical
- Relative Strength Index (RSI)
- BBDO 49.38
- NTRA 55.18
- Support Level
- BBDO $2.69
- NTRA $157.43
- Resistance Level
- BBDO $2.91
- NTRA $164.89
- Average True Range (ATR)
- BBDO 0.10
- NTRA 5.06
- MACD
- BBDO -0.02
- NTRA -1.01
- Stochastic Oscillator
- BBDO 35.48
- NTRA 53.65
About BBDO Banco Bradesco Sa (each representing one Common Share)
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.